Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Philadelphia, Pennsylvania--(Newsfile Corp. - April 1, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo" or the "Company") on behalf of investors who purchased the American Depositary Shares ("ADS") of Mereo during the period from June 5, 2023 through December 26, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Mereo securities during the Class Period may, no later than April 6, 2026, seek to be appointed as a lead plaintiff representative of the class.